Prestige Consumer Healthcare Inc
Research Prestige Consumer Healthcare Inc (PBH) on Bullrun: valuation model: 29.9% undervalued, market cap USD 2.44B, P/E 14.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPBH
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Valuation signal29.9% undervalued
- Market capUSD 2.44B
- P/E14.4
- Financial periodFY2026
- RevenueUSD 1.09B
- Revenue growth-4.3%
- Net incomeUSD 190.30M
- Free cash flowUSD 246.45M
- Gross margin54.7%
Valuation Snapshot
Bullrun's latest valuation model marks Prestige Consumer Healthcare Inc as 29.9% undervalued; latest market cap is USD 2.44B; P/E is 14.4.
Peer valuation comparison
Latest P/E is 14.4x versus a Healthcare sector median of 24.46x (41.1% below).
Latest P/E is 14.4x versus a United States median of 24.87x (42.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 1.09B | USD 190.30M | USD 246.45M | 54.7% | 3.91 | USD 63.87M | USD 993.95M | USD 1.89B |
| FY2025 | USD 1.14B | USD 214.61M | USD 243.29M | 55.8% | 4.29 | USD 97.88M | USD 992.36M | USD 1.83B |
| FY2024 | USD 1.13B | USD 209.34M | USD 239.38M | 55.5% | 4.17 | USD 46.47M | USD 1.14B | USD 1.66B |
| FY2023 | USD 1.13B | -USD 82.31M | USD 221.93M | 55.4% | -1.65 | USD 58.49M | USD 1.35B | USD 1.45B |
| FY2022 | USD 1.09B | USD 205.38M | USD 250.28M | 57.1% | 4.04 | USD 27.19M | USD 1.48B | USD 1.58B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.44B | 14.4 | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.92B | 16.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.87B | 18.3 | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.04B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.10B | 15.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.04B | 16.3 | n/a | n/a |
About Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Prestige Consumer Healthcare Inc overvalued or undervalued?
Bullrun's valuation model currently marks Prestige Consumer Healthcare Inc as 29.9% undervalued.
What is Prestige Consumer Healthcare Inc's market cap?
Prestige Consumer Healthcare Inc's market capitalization is USD 2.44B.
What is Prestige Consumer Healthcare Inc's P/E ratio?
Prestige Consumer Healthcare Inc's price-to-earnings (P/E) ratio is 14.4.
What does Prestige Consumer Healthcare Inc do?
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.